Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02495636
Title Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Yale University
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Rasdegafusp alfa

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06511 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field